# A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion

> **NCT01529957** · PHASE1 · COMPLETED · sponsor: **TaiGen Biotechnology Co., Ltd.** · enrollment: 176 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nemonoxacin Malate Sodium Chloride

## Key facts

- **NCT ID:** NCT01529957
- **Lead sponsor:** TaiGen Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2012-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01529957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01529957, "A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01529957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*